|3Dec 6, 8:55 PM ET

bioMerieux/ADR 3

3 · Quanterix Corp · Filed Dec 6, 2017

Insider Transaction Report

Form 3
Period: 2017-12-06
Holdings
  • Series C Preferred Stock

    Common Stock (2,055,632 underlying)
Footnotes (3)
  • [F1]These shares are convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, at any time after the issuance of such shares, at the holder's election.
  • [F2]Not applicable.
  • [F3]The shares of preferred stock will convert into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock will convert on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security.

Documents

2 files